The FDA has approved a new small molecule inhibitor from Celcuity with blockbuster potential that could become a new standard of care for patients with breast cancer. The regulator is allowing ...

After speedrunning a series of major manufacturing milestones in the past year and a half, the “biotech floodgates” have ...

Huyabio has scored a win in the largest oncology study it has undertaken in its 22 years, as its oral histone deacetylase ...

Nearly a decade after spinning out its Chinese research hub to form Dizal Pharmaceutical, AstraZeneca is paying up to $1.5 billion to buy a piece of the pipeline, securing exclusive global rights for ...

Insulet’s wearable insulin patch Omnipod may be able to seamlessly control insulin delivery for patients with diabetes, but ...

In the second of a new series of interviews with top executives from leading healthcare and comms agencies, Fierce Pharma ...

In an initiative to increase the efficiency of drug manufacturing in the United States, the FDA has proposed a streamlined ...

In what GSK says represents a potential way to transform treatment for patients with certain types of rectal cancer, the ...

Even as the effort has met with fierce pushback from drugmakers, trade groups and opposition parties in the country’s own ...

Lupin Pharmaceuticals, the U.S. unit of India’s Lupin Limited, issued a voluntary recall of more than 2.5 million bottles of prednisolone acetate ophthalmic suspension after an undisclosed contaminant ...

The pharmaceutical industry is reaching a turning point in patient support. | Life sciences leaders say patient support is ...

Sanofi has scored FDA approval for its subcutaneous version of Sarclisa, giving the multiple myeloma treatment a potential ...